On the contrary, 5mC levels were increased in the hippocampus of aging mice, but reduced in APP/PS1 transgenic mice, as well as in the hippocampus, enthorhinal cortex and cerebellum of patients with AD [349]. This evidence concerns the gene APP and Alzheimer disease.